Legal & General Group’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Sell
20,612
-6,164
-23% -$186K ﹤0.01% 2302
2026
Q1
$756K Buy
26,776
+4,110
+18% +$110K ﹤0.01% 2232
2025
Q4
$629K Hold
22,666
– – ﹤0.01% 2351
2025
Q3
$566K Buy
22,666
+11,116
+96% +$247K ﹤0.01% 2409
2025
Q2
$203K Buy
11,550
+1,695
+17% +$27.3K ﹤0.01% 2590
2025
Q1
$155K Hold
9,855
– – ﹤0.01% 2641
2024
Q4
$189K Buy
9,855
+994
+11% +$20.5K ﹤0.01% 2670
2024
Q3
$164K Buy
+8,861
New +$162K ﹤0.01% 2696

Other funds holding PHVS

Legal & General Group's PHVS Position: Q2 2026 in Review

Legal & General Group reduced its Pharvaris (PHVS) stake by 23% in Q2 2026, selling an estimated $186K and leaving 20,612 shares worth $713K. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

Legal & General Group first reported a position in PHVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $756K in Q1 2026. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Legal & General Group held 20,612 shares of Pharvaris worth $713K as of Q2 2026.
  • Legal & General Group sold 6,164 Pharvaris shares in Q2 2026, an estimated $186K.
  • Pharvaris made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2302 holding.
  • Legal & General Group first reported a position in Pharvaris in Q3 2024 and has held it in 8 quarters since.
  • Legal & General Group's Pharvaris position peaked at $756K in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.